Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ANVS — Annovis Bio, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in ANVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$273,054
-$213,835 QoQ
Shares Held
146,804
-32.8% QoQ
Ownership
0.345%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 61 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANVS Over Time

Shares Held

Position Value (USD)

Derivatives in ANVS

reported options exposure · as of Jun 30, 2026
CallValue
$531,774
CallShares
285,900
PutValue
$241,242
PutShares
129,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. ANVS ranks #209 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANVS

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $273,054 146,804
2026-06-30 $531,774 285,900
2026-06-30 $241,242 129,700
2026-03-31 $486,889 218,336
2026-03-31 $497,959 223,300
2026-03-31 $221,662 99,400
2025-12-31 $723,486 209,100
2025-12-31 $269,880 78,000
2025-12-31 $1,049,373 303,287
2025-09-30 $94,599 45,700
2025-09-30 $452,131 218,421
2025-09-30 $95,220 46,000
2025-06-30 $357,090 164,558
2025-06-30 $123,907 57,100
2025-06-30 $112,406 51,800
2025-03-31 $110,550 73,700
2025-03-31 $41,250 27,500
2025-03-31 $191,557 127,705
2024-12-31 $278,219 55,312
2024-12-31 $1,613,121 320,700
2024-12-31 $942,622 187,400
2024-09-30 $254,051 31,520
2024-09-30 $1,052,636 130,600
2024-09-30 $1,491,100 185,000
2024-06-30 $1,914,048 332,300
2024-06-30 $1,929,024 334,900
2024-03-31 $863,963 72,602
2024-03-31 $1,582,700 133,000
2024-03-31 $2,623,950 220,500
2023-12-31 $1,563,320 83,600
2023-12-31 $294,936 15,772
2023-03-31 $212,658 13,800